Long-term users do not have more medication to clear than someone who has only taken it for a few weeks at the same dose
Both Retatrutide and Sermorelin follow specific protocols designed to maximize benefits while minimizing side effects
The proportion of bariatric surgery patients with GLP-1 prescriptions before surgery increased consistently, rising 4X from 1.5% in 2018 to 6.4% in 2023 (Figure 2)
This effect usually resolves as the body adjusts
JAMA Oncology, 10 , 256
Based on Phase 2 trial data (Jastreboff et al., NEJM , 2023), the most commonly reported adverse effects of retatrutide include: Gastrointestinal effects: Nausea, vomiting, diarrhoea, and constipation (most frequent, particularly during dose escalation) Injection site reactions: Redness, bruising, or mild discomfort Decreased appetite: Generally considered a therapeutic effect but can contribute to nutritional deficiency if severe Increased heart rate: Observed with glucagon receptor agonism